Evidence map›Paper›PMID 38600346›Full record

ArticleEMBO reports2024

Foxp1 suppresses cortical angiogenesis and attenuates HIF-1alpha signaling to promote neural progenitor cell maintenance.

Jessie E Buth, Catherine E Dyevich, Alexandra Rubin, Chengbing Wang, Lei Gao, Tessa Marks, Michael Rm Harrison, Jennifer H Kong, M Elizabeth Ross, Bennett G Novitch and 1 more

Abstract read
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jessie E Buth *Department of Neurobiology, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA.
Catherine E Dyevich *Feil Family Brain and Mind Research Institute and Center for Neurogenetics, Weill Cornell Medicine, New York, NY, 10021, USA.
Alexandra RubinFeil Family Brain and Mind Research Institute and Center for Neurogenetics, Weill Cornell Medicine, New York, NY, 10021, USA.
Chengbing WangFeil Family Brain and Mind Research Institute and Center for Neurogenetics, Weill Cornell Medicine, New York, NY, 10021, USA.ORCID 0000-0002-4006-395X
Lei GaoDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.ORCID 0000-0002-7043-4774
Tessa MarksDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.
Michael Rm HarrisonCardiovascular Research Institute, Weill Cornell Medicine, New York, NY, 10021, USA.
Jennifer H KongDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.ORCID 0000-0002-4573-3270
M Elizabeth RossFeil Family Brain and Mind Research Institute and Center for Neurogenetics, Weill Cornell Medicine, New York, NY, 10021, USA.ORCID 0000-0001-6440-8089
Bennett G Novitch *Department of Neurobiology, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA.ORCID 0000-0002-2696-3708
Caroline Alayne Pearson *Feil Family Brain and Mind Research Institute and Center for Neurogenetics, Weill Cornell Medicine, New York, NY, 10021, USA. cap4010@med.cornell.edu.ORCID 0000-0002-1425-7865

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Proteins to Cell SystemsU54NS117170 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ISOM, LORI L., PARENT, JACK M · 2020 to 2024
$11.9M
UCLA IDDRC: Translational CoreP50HD103557 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Peyman Golshani, SUMA JACOB · 2020 to 2026
$9.6M
Integrative Center for Neurogenetics and Neurogenomics - OverallP30NS062691 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI COPPOLA, GIOVANNI, FREIMER, NELSON B. · 2009 to 2018
$7.4M
UCLA Center for Translational Research in Neurodevelopment: UC-TRaNU54HD087101 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCCRACKEN, JAMES T. · 2016 to 2020
$6.5M
Progenitor Regulation Underlying Cortical Interneuron SpecificationR01NS105477 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROSS, MARGARET ELIZABETH · 2018 to 2022
$3.1M
Regulation of neural progenitor functions underlying cortical growth & complexityR01NS089817 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NOVITCH, BENNETT G · 2015 to 2019
$2.1M
Lymphatic Support of Neurogenesis and RegenerationR01NS126209 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Michael Harrison · 2023 to 2026
$1.8M
Molecular mechanisms that regulate target cell sensitivity to Hedgehog morphogensR00GM132518 · NIGMS · UNIVERSITY OF WASHINGTON · PI KONG, JENNIFER · 2023 to 2025
$871k
American Heart Association (AHA) AHA941434California Institute for Regenerative Medicine (CIRM) TG2-01169HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) P50HD103557HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) U54HD087101HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) P30NS062691HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS089817HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS105477HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS126209NCI NIH HHS P30 CA015704NICHD NIH HHS P50 HD103557NICHD NIH HHS U54 HD087101NIGMS NIH HHS R00 GM132518NIH HHS R00GM132518NIH/NCI P30CA015704NINDS NIH HHS P30 NS062691NINDS NIH HHS R01 NS089817NINDS NIH HHS R01 NS105477NINDS NIH HHS R01 NS126209Rose Hills Foundation (RHF) EDUC4-12753
6 · The paper itself

Abstract

Neural progenitor cells within the cerebral cortex undergo a characteristic switch between symmetric self-renewing cell divisions early in development and asymmetric neurogenic divisions later. Yet, the mechanisms controlling this transition remain unclear. Previous work has shown that early but not late neural progenitor cells (NPCs) endogenously express the autism-linked transcription factor Foxp1, and both loss and gain of Foxp1 function can alter NPC activity and fate choices. Here, we show that premature loss of Foxp1 upregulates transcriptional programs regulating angiogenesis, glycolysis, and cellular responses to hypoxia. These changes coincide with a premature destabilization of HIF-1α, an elevation in HIF-1α target genes, including Vegfa in NPCs, and precocious vascular network development. In vitro experiments demonstrate that stabilization of HIF-1α in Foxp1-deficient NPCs rescues the premature differentiation phenotype and restores NPC maintenance. Our data indicate that the endogenous decline in Foxp1 expression activates the HIF-1α transcriptional program leading to changes in the tissue environment adjacent to NPCs, which, in turn, might alter their self-renewal and neurogenic capacities.

Indexed as

Cerebral CortexForkhead Transcription FactorsHypoxia-Inducible Factor 1, alpha SubunitNeural Stem CellsRepressor ProteinsSignal TransductionAngiogenesisAnimalsCell DifferentiationGlycolysisMiceNeovascularization, PhysiologicNeurogenesisVascular Endothelial Growth Factor AForkhead Transcription FactorsHypoxia-Inducible Factor 1, alpha SubunitRepressor ProteinsVascular Endothelial Growth Factor AAngiogenesisAutismCorticogenesisHIF-1 SignalingNeurodevelopment

Identifiers

PMID38600346
PMCPMC11094073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.